Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025796
Filing Date
2021-05-10
Accepted
2021-05-10 08:45:56
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-10q_20210331.htm   iXBRL 10-Q 1934841
2 EX-31.1 hrtx-ex311_8.htm EX-31.1 21769
3 EX-31.2 hrtx-ex312_6.htm EX-31.2 21062
4 EX-32.1 hrtx-ex321_7.htm EX-32.1 17905
  Complete submission text file 0001564590-21-025796.txt   6902636

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20210331.xsd EX-101.SCH 38980
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20210331_cal.xml EX-101.CAL 40982
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20210331_def.xml EX-101.DEF 126472
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20210331_lab.xml EX-101.LAB 334714
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20210331_pre.xml EX-101.PRE 246343
10 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-10q_20210331_htm.xml XML 1346337
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 21905401
SIC: 2834 Pharmaceutical Preparations